Vascular Tissue Engineering is a multidisciplinary field that combines principles of engineering, biology, and materials science to create functional and implantable blood vessels. The goal is to develop innovative strategies to replace or repair damaged blood vessels, addressing challenges in cardiovascular diseases, vascular trauma, and organ transplantation. Various approaches are employed in vascular tissue engineering, including the use of biomaterial scaffolds, cell sources, and bioactive molecules. Biocompatible materials such as polymers and hydrogels serve as scaffolds, providing a framework for cell attachment, proliferation, and tissue formation. Cells play a crucial role in vascular tissue engineering, with endothelial cells and smooth muscle cells often used to populate the scaffold. Endothelial cells form the inner lining of blood vessels, promoting blood compatibility, while smooth muscle cells contribute to vessel structure and contractility. Bioactive molecules, including growth factors and cytokines, are incorporated into the engineered constructs to regulate cellular behavior, promote vascularization, and enhance tissue integration. Bioprinting technologies enable the precise deposition of cells and biomaterials, allowing the creation of complex three-dimensional vascular structures with spatial accuracy. Vascular tissue engineering holds promise for developing off-the-shelf vascular grafts and personalized solutions tailored to individual patient needs. Success in this field may revolutionize treatments for vascular diseases and improve outcomes in cardiovascular surgeries, ultimately contributing to advancements in regenerative medicine and patient care.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy